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Community Acquired Bacteremia in a Paediatric Hospital
Abstract:
Information was collected retrospectively for one year on children presenting with community acquired bacteremia to a
paediatric hospital. Between 1st October 1996 and 31st September 1997. Thirty eight children were identified (21 males
and 17 females). Twenty nine (76%) patients presented directly to the accident and emergency department. Ages ranged
from one week to 14 years (mean 22.8 months, median 8 months). Symptoms occurred for 12 hours to 7 days (mean 2.2
days, median 1 day) prior to presentation and included fever (63%), vomiting (31%), lethargy (31%), poor feeding(28%),
irritability (26%), and diarrhoea (8%). A probable source for the bacteremia was identified retrospectively in a total
of 17 cases; urinary tract infection (7), skin infection (6), septic arthritis (2), and pneumonia (2). Organisms
included N.meningitides (29%). S.pneumococcus (26%), E. coli (18%) and S.aureus (21%). No significant resistance
patterns were identified. Initial empiric antibiotic therapy included cefotaxime in 23 (61%) cases. Thirty five (90%)
patients experienced complete recovery. Three (8%) patients suffered serious sequelae. The introduction of national
HiB vaccination appears to have impacted on the incidence of community acquired bacteremia especially in the younger
age group. Patient outcome following community acquired bacteremia is generally good. Antibiotic resistance has not
yet emerged as a significant problem but current choice of empiric antibiotic therapy may need to be reviewed.
Accident and emergency departments are continuing to be used as primary care centres for sick children in Dublin
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Abstract
Information was collected retrospectively for one year on children presenting with community acquired bacteremia to
a paediatric hospital. Between 1st October 1996 and 31st September 1997. Thirty eight children were identified (21
males and 17 females). Twenty nine (76%) patients presented directly to the accident and emergency department. Ages
ranged from one week to 14 years (mean 22.8 months, median 8 months). Symptoms occurred for 12 hours to 7 days (mean
2.2 days, median 1 day) prior to presentation and included fever (63%), vomiting (31%), lethargy (31%), poor
feeding(28%), irritability (26%), and diarrhoea (8%). A probable source for the bacteremia was identified
retrospectively in a total of 17 cases; urinary tract infection (7), skin infection (6), septic arthritis (2), and
pneumonia (2). Organisms included N.meningitides (29%). S.pneumococcus (26%), E. coli (18%) and S.aureus (21%). No
significant resistance patterns were identified. Initial empiric antibiotic therapy included cefotaxime in 23 (61%)
cases. Thirty five (90%) patients experienced complete recovery. Three (8%) patients suffered serious sequelae. The
introduction of national HiB vaccination appears to have impacted on the incidence of community acquired bacteremia
especially in the younger age group. Patient outcome following community acquired bacteremia is generally good.
Antibiotic resistance has not yet emerged as a significant problem but current choice of empiric antibiotic therapy
may need to be reviewed. Accident and emergency departments are continuing to be used as primary care centres for
sick children in Dublin
Introduction
Children with community acquired bacteremia continue to present to paediatric hospitals. Nation-wide vaccination
against Haemophilus Influenza type B (HiB) has significantly reduced invasive HiB disease in children1. The impact of
emerging penicillin resistance of pneumococci and the prevalence of occult bacteremia in children is unknown. 
There have been no previous systematic reports of community acquired bacteremia in children in the Republic of
Ireland. The aims were to establish baseline epidemiological information on children presenting with community
acquired bacteremia and to describe mode of presentation, choice and appropriateness of antibiotic treatment and
patient outcome and also to identify the organisms responsible for community acquired bacteremia and the prevalence
of significant antimicrobial resistance among these organisms.
Methods
Positive blood cultures were identified retrospectively from the microbiology laboratory records from 1st October
1996 to 31st September 1997. 
Patients were included in the study if they fulfilled the following criteria: Blood cultures were taken in the
accident and emergency department or within 72 hours of admission; A central line was not present in the patient at
the time of blood culture; Coagulase negative Staphylococcusand a haemolytic Streptococcusbacteremia were included
only if obtained from two consecutive blood cultures from the same patient. 
Patient details were obtained by retrospective chart review. Fever was defined as a temperature of >38.50C on
presentation or a sustained temperature of >380C for 4 hours. 
Significant resistant patterns were investigated for each organism as follows: 
E. coli and aminoglycoside resistance, Nesisseria meningococcus and penicillin resistance and Haemophilus influenzae
and ampicillin resistance. 
neonate
(n=6)
infant
(n=17)
1-5y
(n=11)
5-10
(n=2)
10-15
(n=2)
Male
(n=1)
Female
(n=17)
N. meningitides 0 4 6 1 0 5 6
S. pneumonia 1 5 4 0 0 5 5
E. coli 3 4 0 0 0 7 0
S. aureus 2 2 1 1 2 2 6
HiB 1 1
Grp A stremptococus 1 1
Results
Patient details: Between 1st October 1996 and 31st September 1997, thirty eight patients fulfilled the criteria for
community acquired bacteremia and all were admitted to hospital. These represented 0.2% of hospital admissions during
this time period. There were 21 (55%) males and 17 (45%) females. Ages ranged from one week to 14 years (mean 22.8
months, median 8 months). Twelve (32%) presented in the autumn, 11 (29%) in the winter, 10 (26%) in the spring and 5
(13%) in the summer months. 
Twenty nine patients presented directly to the hospital emergency department and 9 presented first to their general
practitioner (GP). Length of symptoms prior to presentation ranged from 12 hours to 7 days (mean 2.2 days, median 1
day). Symptoms included fever (63%), vomiting (31%), lethargy (31%), poor feeding (28%, irritability (26%), and
diarrhoea (8%). 
A probable source of infection was identified at presentation in 8 cases (skin infection (6), septic arthritis (2)).
A probable source for the bacteremia was identified retrospectively in total of 17 cases; sources included urinary
tract infection (7, all E. coli), skin infection (6, all S.aureus), septic arthritis (2, both S.aureus) and pneumonia
(2, both S.pneumonia). 
Microbiology: The organisms identified as responsible for community acquired bacteremia are as outlined in Figure 1.
There were no polymicrobial episodes of bacteremia documented.
There were no significant resistance patterns identified. All isolates of Pneumococus were susceptible to ampicillin.
The prevalence of different organisms responsible for community acquired bacteremia according to different patients
groups is as documented in Fig 1. 
Antibiotic therapy: Three (8%) patients received antibiotics from a general practitioner prior to presentation to the
hospital. Intravenous antibiotics were administered to all cases for a mean of 7.5 days (median 7 days). There was a
mean total number of 2.1 (median 2) antibiotics used for each patient. Initial empiric antibiotic therapy is
summarised in Figure 2. 
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Outcome: Thirty five (90%) patients experienced complete recovery. Three (8%) patients continue to have clinical
sequelae; two with multiple organ failure as a result of N. meningitides infection and one with deafness as a result
of S.pneurnococcus bacteremia and meningitis.
Discussion
Community acquired bacteremia represented 0.2% of hospital admissions in a one year period. All patients were
admitted to hospital with no patient needing to be recalled following a positive result from the laboratory thus
reflecting a low incidence of occult bacteremia. This is in contrast to the United States (US) where occult
bacteremia, most often caused by S.pneumococcus frequently encountered2,3. The most common organisms identified were
N.meningococcus (29%) S.pneumococcus (26%), E. coli (18%) and S. aureus (21%). This spectrum is different to that
which occurs in hospital acquired bacteremia where Gram positive staphylococci and Gram negative organisms tend to
predominate4. Of note, Haemophilus. influenza type B(HiB) was responsible for only one episode of bacteremia. This
decline of H. influenza type B (HiB) bacteremia has occurred in most industrialized countries following the
introduction of childhood HiB vaccination5.
E. coli was the most common organism identified in the neonatal age group (50% of neonatal bacteremia) followed by
S.aureus and S. pneumonia. This, together with the fact that E. coli bacteremia occurred only in males, most probably
reflects the relatively high incidence of urinary tract infection in males of this age group. In the 1-5 year age
group, N.meningitis accounted for most episodes of bacteremia (55%). 
Only 9(24%) patients presented initially to their GP and only 3(8%) received antibiotic therapy prior to presentation
to hospital. In Dublin, accident and emergency departments are frequently the site of initial presentation for sick
children. 
Cefotaxime is a widely used empiric antibiotic for suspected serious infection in children (used in 71% of reported
cases) and is an appropriate choice based on susceptibility patterns2-6. Antibiotic resistance has not yet emerged as
a significant problem in cases of community acquired bacteremia. Children were treated with IV antibiotics for a mean
period of 7.5 days. In many cases, oral antibiotics could have been introduced after a period of defervescence. The
use of co-amoxyclav together with cefotaxime (5 cases; 3 with U.T.I., one with pneumonia and one with bacteremia) is
probably inappropriate. Current practices may need to be reviewed. There was a generally good outcome following
bacteremia in the reported children except for those cases in which meningitis occurred. 
In conclusion, community acquired bacteremia accounts for a relatively small proportion of hospital admissions. The
introduction of national HiB vaccination appears to have impacted on the incidence of bacteremia especially in the
younger age group. Antibiotic resistance has not yet emerged as a significant problem in cases of community acquired
bacteremia. Accident and emergency departments are continuing to be used as primary care centres for sick children in
Dublin.
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